Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Extensive Variability in Platelet Count, Bleeding, and Quality of Life Outcome Measures in Adult and Pediatric Immune Thrombocytopenia: An Appraisal from a Critical Review of the Literature

Hanny Al-Samkari, MD, Alexandria Cronin, MLIS, Donald M. Arnold, MD MSc, Francesco Rodeghiero, MD, Rachael F. Grace, MD

Blood (2020) 136 (Supplement 1): 45–46.

https://doi.org/10.1182/blood-2020-138694

Published: 2020

Journal Articles

Fluid-Phase Immune Complexes Can Assemble and Activate Platelets in Heparin-Induced Thrombocytopenia

Angela Huynh, BSc, Donald M. Arnold, MD MSc, FRCPC, James W. Smith, Taylor D. Elliott, BSc, Hina Bhakta, John G. Kelton, MD, Ishac Nazy, PhD

Blood (2018) 132 (Supplement 1): 3746.

https://doi.org/10.1182/blood-2018-99-115037

Published: 2018

Journal Articles

Urgent Management of Bleeding in Immune Thrombocytopenia: Towards a Standardized Protocol in the Emergency Department

Siraj Mithoowani, MD FRCPC, Andrea Cervi, MD MSc, Nishwa Shah, BHSc, Resham Ejaz, MD FRCPC, Rebecca Barty, MLT, BA, MSc, Na Li, PhD, Ishac Nazy, PhD, Donald M. Arnold, MD MSc, FRCPC

Blood (2018) 132 (Supplement 1): 3517.

https://doi.org/10.1182/blood-2018-99-112997

Published: 2018

Journal Articles

Fostamatinib, a Spleen Tyrosine Kinase Inhibitor, for the Treatment of Warm Antibody Autoimmune Hemolytic Anemia: Initial Results of the Multicenter, Open-Label Extension Period of the Soar Phase 2 Study

David J. Kuter, MD DPhil, Richy Agajanian, MD, Donald M. Arnold, MD MSc, FRCPC, Michael Boxer, MD, Catherine Broome, MD, Joshua J. Field, MD, Irina Murakhovskaya, MD, Kerry A. Rogers, MD, Ann M Lowe, MD, Sandra Tong, MD, Hany Zayed, PhD, Anne-Marie Duliege, MD MS

Blood (2018) 132 (Supplement 1): 3612.

https://doi.org/10.1182/blood-2018-99-110483

Published: 2018

Journal Articles

Patients with Immune Thrombocytopenia (ITP) Frequently Experience Severe Fatigue but Is It Under-Recognized By Physicians: Results from the ITP World Impact Survey (I-WISh)

Caroline Kruse, Alexandra Kruse, Shirley Watson, Mervyn Morgan, Nichola Cooper, MRCP, Waleed Ghanima, Andrew Provan, Donald M. Arnold, MD MSc, FRCPC, Cristina Santoro, Ming Hou, MD, Yoshiaki Tomiyama, MD, Serge Laborde, Barbara Lovrencic, John Waller, PhD BSc, Gavin Taylor-Stokes, Tom Bailey, Miona Stankovic, James B. Bussel, MD

Blood (2018) 132 (Supplement 1): 2273.

https://doi.org/10.1182/blood-2018-99-112378

Published: 2018

Journal Articles

Predictors of Remission in Adults with Immune Thrombocytopenia Treated with Romiplostim

Adrian Newland, MA, FRCP, FRCPath, James B. Bussel, MD, Robert Bird, FRACP, FRCP, FRCPA, MBBS, MRCP, Donald M. Arnold, MD MSc, FRCPC, Craig M. Kessler, Jiří Mayer, Monica Tejeda Romero, Ann Janssens, Kejia Wang, PhD, Melissa Jeanne Eisen, MD

Blood (2018) 132 (Supplement 1): 735.

https://doi.org/10.1182/blood-2018-99-109791

Published: 2018

Journal Articles

Two-Year Safety and Efficacy Outcomes with Fostamatinib in Adult Patients with Immune Thrombocytopenia (ITP): Open-Label Extension to Phase 3 Trial Program

Anne-Marie Duliege, MDMS, Donald M. Arnold, MD MSc, FRCPC, Ralph Boccia, MD, Michael Boxer, MD, Nichola Cooper, MRCP, Quentin A Hill, BSc, MBChB, MRCP, FRCPath, Darla K Liles, MD, Michelle Sholzberg, MDM, MSc, FRCPC, Hany Zayed, PhD, Sandra Tong, MD, James B. Bussel, MD

Blood (2018) 132 (Supplement 1): 736.

https://doi.org/10.1182/blood-2018-99-110482

Published: 2018

Journal Articles

Perioperative Anticoagulant Use for Surgery Evaluation (PAUSE) Study: A Perioperative Management Plan for Patients with Atrial Fibrillation Who Are Receiving a Direct Oral Anticoagulant

Blood (2018) 132 (Supplement 1): LBA-5.

https://doi.org/10.1182/blood-2018-120770

Published: 2018

Journal Articles

Fetal-Neonatal Alloimmune Thrombocytopenia (FNAIT): Guidance to Reduce the Risk of Intracranial Bleeding

Blood (2018) 132 (Supplement 1): 4717.

https://doi.org/10.1182/blood-2018-99-109906

Published: 2018

Journal Articles

Results from the ITP World IMPACT Survey (I-WISh): Patients with Immune Thrombocytopenia (ITP) Experience Impaired Quality of Life (QoL) Regarding Daily Activities, Social Interactions, Emotional Well-Being and Working Lives

Nichola Cooper, MRCP, Alexandra Kruse, Caroline Kruse, Shirley Watson, Mervyn Morgan, James B. Bussel, MD, Waleed Ghanima, Donald M. Arnold, MD MSc, FRCPC, Cristina Santoro, Ming Hou, MD, Yoshiaki Tomiyama, MD, Serge Laborde, Barbara Lovrencic, John Waller, PhD BSc, Tom Bailey, Gavin Taylor-Stokes, Miona Stankovic, Andrew Provan

Blood (2018) 132 (Supplement 1): 4804.

https://doi.org/10.1182/blood-2018-99-112858

Published: 2018

Journal Articles

The Mcmaster ITP Registry: Assessing the Prevalence, Clinical and Laboratory Features of Immune Thrombocytopenia

Donald M. Arnold, MD MSc, Rumi Clare, B.Sc., Mary Salib, MD, Robert Clayden, Grace Wang, MMath, Ishac Nazi, PhD, John G. Kelton, MD FRCPC

Blood (2014) 124 (21): 5008.

https://doi.org/10.1182/blood.V124.21.5008.5008

Published: 2014

Journal Articles

A Phase II Study Evaluating the Efficacy of Rituximab in the Management of Patients with Relapsed or Refractory TTP

Stephen Ronan Foley, MD FRCPC, Gail Rock, PhD MD, David Barth, MD FRCPC, Donald M. Arnold, MD MSc, Kathryn E Webert, MD FRCP(C), Paul R. Yenson, MD FRCPC, John G. Kelton, MD FRCPC, William Foster Clark, MD, Lihua Li

Blood (2014) 124 (21): 4191.

https://doi.org/10.1182/blood.V124.21.4191.4191

Published: 2014

Journal Articles

Difficulties in Establishing the Cause of Thrombocytopenia Among Ambulatory Patients Referred to Hematology: An Agreement Study

Mary Salib, MD, Robert Clayden, Rumi Clare, B.Sc., Grace Wang, MMath, Theodore E. Warkentin, MD, Mark A. Crowther, MD, Wendy Lim, MD MSc., FRCPC, Donald M. Arnold, MD MSc

Blood (2014) 124 (21): 3521.

https://doi.org/10.1182/blood.V124.21.3521.3521

Published: 2014

Journal Articles

Use of Intravenous Immune Globulin in Patients with Immune Thrombocytopenia Before and After Romiplostim: Real-World Experience

Korinne Hamilton, MSc, CCRA, Lisa J. Toltl, PhD, Grace Wang, MMath, Naushin S Sholapur, BHSc., MSc HRM candidate, Julie Carruthers, MLT, BComm, Cyrus C. Hsia, BSc, MD, FRCPC, Caroline Hamm, MD, FRCPC, Normand Blais, MD, MSC, FRCPC, Catherine Girard-Desbiens, MD, MSc, Marc-Andre Pearson, MDCM, Nancy Heddle, MSc, Donald M. Arnold, MD, MSc.

Blood (2012) 120 (21): 4641.

https://doi.org/10.1182/blood.V120.21.4641.4641

Published: 2012

Journal Articles

Reporting Bleeding Outcomes in Adult and Pediatric Studies of Primary Immune Thrombocytopenia: A Systematic Review

Nastaran Noroozi, MD, FRCPC, Cindy Neunert, MD, Jennifer K Goy, MD, George R. Buchanan, MD, Victor S. Blanchette, MD, FRCPC, Donald M. Arnold, MD, MSc.

Blood (2012) 120 (21): 4281.

https://doi.org/10.1182/blood.V120.21.4281.4281

Published: 2012

Journal Articles

Persistent Impairments in Humoral and Cellular Immunity in Patients with Immune Thrombocytopenia Treated with Rituximab: A Sub-Study of a Randomized Controlled Trial

Ishac Nazi, Ph.D., John G. Kelton, MD, FRCPC, Mark Larche, Ph.D., Denis P. Snider, Ph.D., Jane C. Moore, B.Sc., James W. Smith, B.Sc., Rumi Clare, B.Sc., Diana M. Moffatt, Joecyln Tufts, Donald M. Arnold, MD, MSc.

Blood (2012) 120 (21): 492.

https://doi.org/10.1182/blood.V120.21.492.492

Published: 2012

Journal Articles

An Individual Platelet Count Set-Point in ITP: A Concept Learned from Patients with Mild Thrombocytopenia and a Good Response to IVIg or Corticosteroids.

Donald M. Arnold, MD, MSc, Jane C. Moore, James W. Smith, John G. Kelton, MD

Blood (2007) 110 (11): 3926.

https://doi.org/10.1182/blood.V110.11.3926.3926

Published: 2007

NARROW

Extensive Variability in Platelet Count, Bleeding, and Quality of Life Outcome Measures in Adult and Pediatric Immune Thrombocytopenia: An Appraisal from a Critical Review of the Literature

Fluid-Phase Immune Complexes Can Assemble and Activate Platelets in Heparin-Induced Thrombocytopenia

Urgent Management of Bleeding in Immune Thrombocytopenia: Towards a Standardized Protocol in the Emergency Department

Fostamatinib, a Spleen Tyrosine Kinase Inhibitor, for the Treatment of Warm Antibody Autoimmune Hemolytic Anemia: Initial Results of the Multicenter, Open-Label Extension Period of the Soar Phase 2 Study

Patients with Immune Thrombocytopenia (ITP) Frequently Experience Severe Fatigue but Is It Under-Recognized By Physicians: Results from the ITP World Impact Survey (I-WISh)

Predictors of Remission in Adults with Immune Thrombocytopenia Treated with Romiplostim

Two-Year Safety and Efficacy Outcomes with Fostamatinib in Adult Patients with Immune Thrombocytopenia (ITP): Open-Label Extension to Phase 3 Trial Program

Perioperative Anticoagulant Use for Surgery Evaluation (PAUSE) Study: A Perioperative Management Plan for Patients with Atrial Fibrillation Who Are Receiving a Direct Oral Anticoagulant

Fetal-Neonatal Alloimmune Thrombocytopenia (FNAIT): Guidance to Reduce the Risk of Intracranial Bleeding

Results from the ITP World IMPACT Survey (I-WISh): Patients with Immune Thrombocytopenia (ITP) Experience Impaired Quality of Life (QoL) Regarding Daily Activities, Social Interactions, Emotional Well-Being and Working Lives

The Mcmaster ITP Registry: Assessing the Prevalence, Clinical and Laboratory Features of Immune Thrombocytopenia

A Phase II Study Evaluating the Efficacy of Rituximab in the Management of Patients with Relapsed or Refractory TTP

Difficulties in Establishing the Cause of Thrombocytopenia Among Ambulatory Patients Referred to Hematology: An Agreement Study

Use of Intravenous Immune Globulin in Patients with Immune Thrombocytopenia Before and After Romiplostim: Real-World Experience

Reporting Bleeding Outcomes in Adult and Pediatric Studies of Primary Immune Thrombocytopenia: A Systematic Review

Persistent Impairments in Humoral and Cellular Immunity in Patients with Immune Thrombocytopenia Treated with Rituximab: A Sub-Study of a Randomized Controlled Trial

An Individual Platelet Count Set-Point in ITP: A Concept Learned from Patients with Mild Thrombocytopenia and a Good Response to IVIg or Corticosteroids.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only